一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0900 | -0.0900 | 0 | -0.1400 | | 每股净资产（元） | 3.12 | 3.08 | 1.3 | 3.22 | | 每股公积金(元) | 2.36 | 2.31 | 2.16 | 2.3 | | 每股未分配利润(元) | -0.85 | -0.85 | 0 | -0.71 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.37 | 3.24 | 4.01 | 3.61 | | 净利润(亿元) | -0.26 | -0.25 | -4 | -0.41 | | 净资产收益率(%) | -2.94 | -2.62 | -12.21 | -4.38 | 数据四舍五入，查看更多财务数据>> | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | ...

前十大流通股东累计持有： 3363.51万股，累计占流通股比： 37.5%，较上期变化： 203.35万 股。 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.1600 | 0.3400 | -52.94 | 0.1400 | | 每股净资产（元） | 5.08 | 4.76 | 6.72 | 4.36 | | 每股公积金(元) | 1.3 | 1.28 | 1.56 | 1.22 | | 每股未分配利润(元) | 2.34 | 2.09 | 11.96 | 1.77 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.25 | 1.81 | -30.94 | 0.91 | | 净利润(亿元) | 0.24 | 0.51 | -52.94 | 0.2 | | 净资产收益率(%) | 3.15 | 7.34 | -57.08 | 3.18 | 数据四舍五入，查看更多财务数据>> 二、 ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0100 | -0.0180 | 44.44 | 0.0060 | | 每股净资产（元） | 1.82 | 1.88 | -3.19 | 1.83 | | 每股公积金(元) | 0.14 | 0.14 | 0 | 0.14 | | 每股未分配利润(元) | 0.53 | 0.61 | -13.11 | 0.56 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 2.5 | 2 | 25 | 1.89 | | 净利润(亿元) | -0.03 | -0.06 | 50 | 0.02 | | 净资产收益率(%) | -0.55 | -0.94 | 41.49 | 0.31 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 三、分红送配方案情况 本次公司不分配不转赠。 前十大流通股东累计持有： 3908.01万股，累 ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0600 | 0.0600 | 0 | -0.0600 | | 每股净资产（元） | 5.92 | 5.78 | 2.42 | 7.55 | | 每股公积金(元) | 2.63 | 2.68 | -1.87 | 3.78 | | 每股未分配利润(元) | 1.98 | 1.87 | 5.88 | 2.30 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.1 | 3.02 | 2.65 | 1.96 | | 净利润(亿元) | 0.13 | 0.13 | 0 | -0.12 | | 净资产收益率(%) | 1.03 | 1.03 | 0 | -0.99 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 13850.5万股，累计占流通股比： 64.01%，较上期变化： -154.01 ...

Financial Performance - The company reported a basic earnings per share of -0.1294 yuan for Q1 2025, an improvement of 57.25% compared to -0.3027 yuan in Q1 2024 [1] - The total revenue for Q1 2025 was 2.86 billion yuan, representing a 42.29% increase from 2.01 billion yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.69 billion yuan, showing a 54.61% improvement from -1.52 billion yuan in Q1 2024 [1] - The return on equity for Q1 2025 was -6.67%, a significant improvement from -15.19% in Q1 2024 [1] Shareholder Information - The top ten unrestricted shareholders collectively hold 17,856.85 million shares, accounting for 33.54% of the circulating shares, with a decrease of 1,649.9 thousand shares compared to the previous period [2] - Notable shareholders include Chen Donggen with 12,981.16 million shares (24.38%), and Chen Weidong with 1,499.00 million shares (2.82%), both of whom did not change their holdings [3] - New entrants among the top shareholders include 招商量化精选股票A with 739.12 million shares (1.39%) and 中信证券股份有限公司 with 258.42 million shares (0.49%) [3] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]

Financial Performance - The company reported a basic earnings per share of -0.0383 yuan for Q1 2025, a decrease of 155.33% compared to Q1 2024, which was -0.0150 yuan [1] - The net profit for Q1 2025 was -0.1 billion yuan, representing a 150% decline from -0.04 billion yuan in Q1 2024 [1] - Operating revenue decreased by 39.13% to 0.28 billion yuan in Q1 2025 from 0.46 billion yuan in Q1 2024 [1] - The return on equity was -1.36% in Q1 2025, a significant drop from -0.46% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 12,626.5 million shares, accounting for 50.09% of the circulating shares, with an increase of 1,943.6 thousand shares compared to the previous period [1] - Ningbo Beilun Helen Investment Co., Ltd. remains the largest shareholder with 6,931.68 million shares, representing 27.49% of the total share capital [2] - Four new shareholders entered the top ten list, while five previous shareholders exited [2][3] Dividend Policy - The company has decided not to distribute dividends or transfer shares in the current period [4]

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0017 | 0.0307 | -94.46 | 0.0128 | | 每股净资产（元） | 3.58 | 3.73 | -4.02 | 3.66 | | 每股公积金(元) | 2.93 | 2.93 | 0 | 2.93 | | 每股未分配利润(元) | -0.39 | -0.26 | -50 | -0.32 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.68 | 1.12 | 50 | 1.33 | | 净利润(亿元) | 0.01 | 0.18 | -94.44 | 0.07 | | 净资产收益率(%) | 0.05 | 0.83 | -93.98 | 0.35 | 本次公司不分配不转赠。 前十大流通股东累计持有： 20492.3万股，累计占流通股比： 35.76%，较上期变化： -68.20万股。 | 名称 | 持有数量 ...

二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 11093.86万股，累计占流通股比： 27.64%，较上期变化： -2550.90万股。 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.1000 | -0.1400 | 28.57 | -0.2000 | | 每股净资产（元） | 3.06 | 3.35 | -8.66 | 3.67 | | 每股公积金(元) | 6.58 | 6.52 | 0.92 | 6.41 | | 每股未分配利润(元) | -4.50 | -4.14 | -8.7 | -3.72 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.08 | 0.09 | -11.11 | 0 | | 净利润(亿元) | -0.57 | -0.83 | 31.33 | -1.18 | | 净资产收益率(%) | -3.21 | -4.23 | 24.11 | ...

Financial Data and Indicators - The basic earnings per share for Q1 2025 is -0.2300 yuan, showing a 20.69% improvement compared to -0.2900 yuan in Q1 2024 [1] - The net asset per share decreased by 43.94% to 1.48 yuan from 2.64 yuan in the previous year [1] - The operating revenue for Q1 2025 increased by 27.78% to 2.07 billion yuan compared to 1.62 billion yuan in Q1 2024 [1] - The net profit for Q1 2025 is -0.93 billion yuan, an improvement of 21.85% from -1.19 billion yuan in Q1 2024 [1] - The return on equity for Q1 2025 is -14.11%, a decline of 36.72% from -10.32% in Q1 2024 [1] Shareholder Information - The top ten unrestricted shareholders hold a total of 31,408.05 million shares, accounting for 75.84% of the circulating shares, with a decrease of 384.87 million shares compared to the previous period [2] - Guangzhou Qixi Group Co., Ltd. holds 15,999.03 million shares, representing 38.64% of the total share capital, with no change [3] - Therabio International Limited holds 4,717.77 million shares, accounting for 11.39% of the total share capital, with no change [3] - New Yu City Qiheng Management Consulting Partnership (Limited Partnership) decreased its holdings by 384.87 million shares to 1,614.31 million shares, representing 3.90% of the total share capital [3] Dividend Distribution - The company will not distribute dividends or transfer shares this time [4]

Financial Performance - The company reported a basic earnings per share of -0.1300 yuan for Q1 2025, an improvement of 40.91% compared to -0.2200 yuan in Q1 2024, but a decline from 0.0500 yuan in Q1 2023 [1] - The net profit for Q1 2025 was -0.08 billion yuan, showing a 27.27% improvement from -0.11 billion yuan in Q1 2024, but a decrease from 0.02 billion yuan in Q1 2023 [1] - The operating revenue increased by 29.63% to 0.35 billion yuan in Q1 2025, compared to 0.27 billion yuan in Q1 2024, and up from 0.2 billion yuan in Q1 2023 [1] - The return on equity was -2.00% in Q1 2025, an improvement from -2.76% in Q1 2024, but a decline from 0.68% in Q1 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 16.2448 million shares, accounting for 50.89% of the circulating shares, with a decrease of 345,000 shares compared to the previous period [2] - Liu Wenyiyi remains the largest shareholder with 8.7412 million shares, representing 27.38% of the total share capital, with no change [3] - Liu Miao's holdings decreased by 29.80% to 3.3521 million shares, now accounting for 10.50% of the total share capital [3] - The previous top shareholder Zhang Binjun has exited the top ten list, holding 0.1573 million shares [3] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [4]